Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (OTCMKTS:SFOSF) Sees Large Increase in Short Interest

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (OTCMKTS:SFOSF) was the target of a significant growth in short interest in December. As of December 31st, there was short interest totaling 301,151 shares, a growth of 6,375.0% from the December 15th total of 4,651 shares. Based on an average daily volume of 105 shares, the days-to-cover ratio is currently 2,868.1 days. Based on an average daily volume of 105 shares, the days-to-cover ratio is currently 2,868.1 days.

Shanghai Fosun Pharmaceutical (Group) Stock Performance

SFOSF remained flat at $2.78 during trading on Monday. The firm’s fifty day simple moving average is $3.12 and its two-hundred day simple moving average is $2.84. Shanghai Fosun Pharmaceutical has a twelve month low of $1.62 and a twelve month high of $3.50.

About Shanghai Fosun Pharmaceutical (Group)

Shanghai Fosun Pharmaceutical (Group) Co, Ltd. is a China‐based healthcare company and a core subsidiary of Fosun International. The company operates across drug manufacturing, distribution and retail services, and health management. Its product portfolio includes generic and proprietary small‐molecule drugs, bio‐pharmaceuticals, vaccines and traditional Chinese patent medicines. Through integrated R&D capabilities and strategic partnerships, Fosun Pharmaceutical pursues innovation across therapeutic areas such as oncology, cardiovascular, metabolic and infectious diseases.

The pharmaceutical manufacturing segment encompasses chemical pharmaceuticals, Chinese patent medicines and biological products, while the distribution arm manages one of the largest drug distribution networks in China, supplying hospitals, clinics and retail pharmacies.